Last reviewed · How we verify

SUBLIVAC® Grasses/Placebo treatment

HAL Allergy · Phase 3 active Small molecule

SUBLIVAC® Grasses/Placebo treatment is a Allergen immunotherapy Small molecule drug developed by HAL Allergy. It is currently in Phase 3 development for Grass allergy treatment.

SUBLIVAC is an allergen immunotherapy that works by desensitizing the body to specific allergens.

SUBLIVAC is an allergen immunotherapy that works by desensitizing the body to specific allergens. Used for Grass allergy treatment.

At a glance

Generic nameSUBLIVAC® Grasses/Placebo treatment
SponsorHAL Allergy
Drug classAllergen immunotherapy
ModalitySmall molecule
Therapeutic areaImmunology
PhasePhase 3

Mechanism of action

It does this by introducing small amounts of the allergen to the body, allowing the immune system to build up a tolerance over time. This can help to reduce symptoms and improve quality of life for individuals with allergies.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about SUBLIVAC® Grasses/Placebo treatment

What is SUBLIVAC® Grasses/Placebo treatment?

SUBLIVAC® Grasses/Placebo treatment is a Allergen immunotherapy drug developed by HAL Allergy, indicated for Grass allergy treatment.

How does SUBLIVAC® Grasses/Placebo treatment work?

SUBLIVAC is an allergen immunotherapy that works by desensitizing the body to specific allergens.

What is SUBLIVAC® Grasses/Placebo treatment used for?

SUBLIVAC® Grasses/Placebo treatment is indicated for Grass allergy treatment.

Who makes SUBLIVAC® Grasses/Placebo treatment?

SUBLIVAC® Grasses/Placebo treatment is developed by HAL Allergy (see full HAL Allergy pipeline at /company/hal-allergy).

What drug class is SUBLIVAC® Grasses/Placebo treatment in?

SUBLIVAC® Grasses/Placebo treatment belongs to the Allergen immunotherapy class. See all Allergen immunotherapy drugs at /class/allergen-immunotherapy.

What development phase is SUBLIVAC® Grasses/Placebo treatment in?

SUBLIVAC® Grasses/Placebo treatment is in Phase 3.

What are the side effects of SUBLIVAC® Grasses/Placebo treatment?

Common side effects of SUBLIVAC® Grasses/Placebo treatment include Local reactions, Systemic reactions.

Related